Long-term Pulmonary Outcomes After Infection With Sars-CoV-2

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

218 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-18

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study

NCT04605757

SARS-COV-2 Pneumonia

UNKNOWN

Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia

NCT04422613

Pneumonia, Viral

COMPLETED NA

Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

NCT04916834

Covid19 SARS-CoV Infection Pulmonary Function +1 more

UNKNOWN

Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia

NCT04599998

Covid19

COMPLETED

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

NCT04581135

COVID-19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be invited to follow-up visits 3 and 12 months after hospitalization with COVID19.

Inclusion will take place during 2020. We expect to enroll 180 non-ICU patients and 36 ICU patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sars-CoV2 Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Imaging of the lungs

After hospital admissions with COVID19 patients will come for two clinical visits to complete a number of questionnaires, pulmonary function testing, six-minute walk test, blood sampling and imaging of the lungs.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Blood sampling Health related quality of life measurements Pulmonary function tests

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infection with Sars-CoV-2

Exclusion Criteria

* Unable to attend hospital visits due to frailty or severe disease
* Unable to understand and complete questionnaires due to intellectual or language limitations / deficits

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No